CLARIANE overview

Regulatory News: Clariane (CLARIA.PA – ISIN FR0010386334) announces its 2023 half-year results. FINANCIALS H1 2023 H1 2022 Growth Organic growth Revenue 2,484.8 2,215.4 12.2% 9.3% France 1,096.0 1,024.4 7.0% 5.9% Germany 573.0 531.6 7.8% 13.0% Benelux 367.9 318.0 15.7% 15.9% Italy 311.5 273.6 13.9% 8.0% Spain, UK 136.4 67.8 101.2% 6.4% EBITDAR (margin) – pre-IFRS16 538.3 (21.7%) 523.1 (23.6%) +2.9% EBITDA (margin) – pre-IFRS16 285.3 (11.5%) 284.9 (12.9%) +0.1% EBITDA (margin) –...

Regulatory News: Term loan extension to 2026 Clariane (Paris:CLARI) announces today the signature of the extension to May 2026 of its term loan for an amount of €505 million, slightly above initial amount, in line with the maturity of the existing Group Revolving Credit Facility (RCF) of €492.5m. All existing banks remain part of the extended term loan, and two new banks have joined the syndicate. Some Schuldschein lenders have transferred their positions into the extended term loan. This...

Regulatory News: Clariane (Paris:CLARI): The Combined General Meeting of shareholders held on 15 June 2023 (the " Meeting ") decided to pay a dividend of €0.25 per share for the financial year 2022, with an option to receive payment in new shares. The issue price of the new shares was set at €6.86, corresponding to 95 % of the average of the opening share price of Clariane shares ( ex Korian) on the regulated market Euronext Paris for the 20 trading days preceding the date of the Meeting,...

Regulatory News: Clariane, the leading European community in care, healthcare and hospitality in times of vulnerability, announces entrusting BNP Paribas Exane, from 3 July 2023 to 31 December 2023 and renewable by tacit agreement for successive one-year periods, with the implementation of a liquidity contract relating to its ordinary shares. This contract was established in accordance with the regulations in force, and in particular AMF Decision No. 2021-01 of June 22, 2021. It complies with...